TransMedics Group, Inc. (TMDX)
85.30
-8.72
(-9.27%)
USD |
NASDAQ |
Nov 20, 16:00
85.99
+0.69
(+0.81%)
After-Hours: 20:00
TransMedics Group Total Long Term Debt (Quarterly) : 863.26M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 863.26M |
| June 30, 2026 | 864.07M |
| March 31, 2026 | 859.91M |
| December 31, 2025 | 515.97M |
| September 30, 2025 | 516.11M |
| June 30, 2025 | 515.80M |
| March 31, 2025 | 515.62M |
| December 31, 2024 | 515.56M |
| September 30, 2024 | 515.60M |
| June 30, 2024 | 514.35M |
| March 31, 2024 | 514.14M |
| December 31, 2023 | 513.91M |
| September 30, 2023 | 513.67M |
| June 30, 2023 | 513.13M |
| March 31, 2023 | 65.83M |
| December 31, 2022 | 66.11M |
| September 30, 2022 | 66.33M |
| June 30, 2022 | 43.62M |
| March 31, 2022 | 43.84M |
| December 31, 2021 | 43.80M |
| Date | Value |
|---|---|
| September 30, 2021 | 35.06M |
| June 30, 2021 | 34.92M |
| March 31, 2021 | 34.79M |
| December 31, 2020 | 34.66M |
| September 30, 2020 | 34.52M |
| June 30, 2020 | 34.40M |
| March 31, 2020 | 34.27M |
| December 31, 2019 | 34.15M |
| September 30, 2019 | 34.02M |
| June 30, 2019 | 33.90M |
| March 31, 2019 | 33.78M |
| December 31, 2018 | 33.67M |
| September 30, 2018 | 33.56M |
| June 30, 2018 | 33.44M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 8.652M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Boston Scientific Corp. | 11.95B |
| Insulet Corp. | 962.10M |
| Abbott Laboratories | 31.16B |
| Baxter International, Inc. | 8.012B |
| Becton, Dickinson & Co. | 13.42B |